Cargando…
Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: A case report
RATIONALE: Double primary clear cell carcinomas of the liver (PCCCL) and kidney are extremely rare; moreover, there have been no reported cases of adrenal metastasis from primary clear cell tumors of the liver. PATIENT CONCERNS: A 47-year-old male patient was admitted to our clinic with space-occupy...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676612/ https://www.ncbi.nlm.nih.gov/pubmed/33217850 http://dx.doi.org/10.1097/MD.0000000000023263 |
_version_ | 1783611808672645120 |
---|---|
author | Jiang, Hua Zhao, Shanchao Li, Ganhong |
author_facet | Jiang, Hua Zhao, Shanchao Li, Ganhong |
author_sort | Jiang, Hua |
collection | PubMed |
description | RATIONALE: Double primary clear cell carcinomas of the liver (PCCCL) and kidney are extremely rare; moreover, there have been no reported cases of adrenal metastasis from primary clear cell tumors of the liver. PATIENT CONCERNS: A 47-year-old male patient was admitted to our clinic with space-occupying lesions in the left kidney and liver during a regular medical examination. DIAGNOSES: The tumors in the kidney and liver were diagnosed as primary clear cell carcinoma by histopathological examination. INTERVENTIONS: The patient subsequently underwent nephron-sparing surgery of the left kidney and radical partial excision of the right liver lobe by laparoscopic surgery. Transcatheter arterial chemoembolization (TACE) was performed for the patient 2 weeks after tumor resection. One month after the operation, the patient started adjuvant therapy with sorafenib (400 mg twice per day orally). However, follow-up CT imaging revealed a solid mass measuring 1.9 × 2.0 × 2.0 cm(3) in the right adrenal gland at 2 months postoperatively, and then the patient underwent radiofrequency ablation (RFA) for the right adrenal tumor. OUTCOMES: The patient remained cancer free for 2 years following the diagnosis despite early right adrenal metastasis. LESSONS: Hepatocyte immunostaining is sufficient for the diagnosis of PCCCL. |
format | Online Article Text |
id | pubmed-7676612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-76766122020-11-24 Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: A case report Jiang, Hua Zhao, Shanchao Li, Ganhong Medicine (Baltimore) 4100 RATIONALE: Double primary clear cell carcinomas of the liver (PCCCL) and kidney are extremely rare; moreover, there have been no reported cases of adrenal metastasis from primary clear cell tumors of the liver. PATIENT CONCERNS: A 47-year-old male patient was admitted to our clinic with space-occupying lesions in the left kidney and liver during a regular medical examination. DIAGNOSES: The tumors in the kidney and liver were diagnosed as primary clear cell carcinoma by histopathological examination. INTERVENTIONS: The patient subsequently underwent nephron-sparing surgery of the left kidney and radical partial excision of the right liver lobe by laparoscopic surgery. Transcatheter arterial chemoembolization (TACE) was performed for the patient 2 weeks after tumor resection. One month after the operation, the patient started adjuvant therapy with sorafenib (400 mg twice per day orally). However, follow-up CT imaging revealed a solid mass measuring 1.9 × 2.0 × 2.0 cm(3) in the right adrenal gland at 2 months postoperatively, and then the patient underwent radiofrequency ablation (RFA) for the right adrenal tumor. OUTCOMES: The patient remained cancer free for 2 years following the diagnosis despite early right adrenal metastasis. LESSONS: Hepatocyte immunostaining is sufficient for the diagnosis of PCCCL. Lippincott Williams & Wilkins 2020-11-20 /pmc/articles/PMC7676612/ /pubmed/33217850 http://dx.doi.org/10.1097/MD.0000000000023263 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 4100 Jiang, Hua Zhao, Shanchao Li, Ganhong Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: A case report |
title | Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: A case report |
title_full | Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: A case report |
title_fullStr | Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: A case report |
title_full_unstemmed | Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: A case report |
title_short | Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: A case report |
title_sort | simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: a case report |
topic | 4100 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676612/ https://www.ncbi.nlm.nih.gov/pubmed/33217850 http://dx.doi.org/10.1097/MD.0000000000023263 |
work_keys_str_mv | AT jianghua simultaneousrenalclearcellcarcinomaandprimaryclearcellcarcinomaoftheliveracasereport AT zhaoshanchao simultaneousrenalclearcellcarcinomaandprimaryclearcellcarcinomaoftheliveracasereport AT liganhong simultaneousrenalclearcellcarcinomaandprimaryclearcellcarcinomaoftheliveracasereport |